DEVELOPMENT AGREEMENTDevelopment Agreement • May 25th, 2004 • Acadia Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
Contract Type FiledMay 25th, 2004 Company Industry JurisdictionTHIS DEVELOPMENT AGREEMENT (this “Agreement”) is entered into as of May 3, 2004 (the “Effective Date”) by and between ACADIA PHARMACEUTICALS INC., a Delaware corporation (“ACADIA”), with offices at 3911 Sorrento Valley Blvd., San Diego, California 92121, and THE STANLEY MEDICAL RESEARCH INSTITUTE, a nonprofit organization (“SMRI”), having offices at 5430 Grosvenor Lane, Suite 200, Bethesda, Maryland 20814.
DEVELOPMENT AGREEMENTDevelopment Agreement • May 5th, 2004 • Acadia Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
Contract Type FiledMay 5th, 2004 Company Industry JurisdictionTHIS DEVELOPMENT AGREEMENT (this “Agreement”) is entered into as of May 3, 2004 (the “Effective Date”) by and between ACADIA PHARMACEUTICALS INC., a Delaware corporation (“ACADIA”), with offices at 3911 Sorrento Valley Blvd., San Diego, California 92121, and THE STANLEY MEDICAL RESEARCH INSTITUTE, a nonprofit organization (“SMRI”), having offices at 5430 Grosvenor Lane, Suite 200, Bethesda, Maryland 20814.